ISEC Healthcare forms joint venture to build ophthalmology centre in Johor

SGX Filings

2025/12/31

ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to incorporate ISEC (Batu Pahat) Sdn. Bhd. in Malaysia.

The new company will establish, operate and manage an ophthalmology centre in Batu Pahat, Johor. Initial issued capital will be 110 Malaysian ringgit shares, rising to RM1,064,890—about 0.34 million Singapore dollars—within nine months through new share subscriptions.

After the capital increase, ISEC Sdn. Bhd. will own 71.83% of the joint venture, which will be treated as an indirect subsidiary of ISEC Healthcare.

ISEC Healthcare will finance its contribution from internal resources. The firm said the transaction is classified as a non-discloseable event under Catalist Rule 1006 and will not materially affect its net tangible assets or earnings per share for the year ending Dec, 31 2025.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1119313168"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1119313168\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1119313168?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-31 20:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119313168","market":"sg","top_or_hot":-1,"title":"ISEC Healthcare forms joint venture to build ophthalmology centre in Johor","media":"SGX Filings","content":"<p>ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to incorporate ISEC (Batu Pahat) Sdn. Bhd. in Malaysia.</p>\n<p>The new company will establish, operate and manage an ophthalmology centre in Batu Pahat, Johor. Initial issued capital will be 110 Malaysian ringgit shares, rising to RM1,064,890—about 0.34 million Singapore dollars—within nine months through new share subscriptions.</p>\n<p>After the capital increase, ISEC Sdn. Bhd. will own 71.83% of the joint venture, which will be treated as an indirect subsidiary of ISEC Healthcare.</p>\n<p>ISEC Healthcare will finance its contribution from internal resources. The firm said the transaction is classified as a non-discloseable event under Catalist Rule 1006 and will not materially affect its net tangible assets or earnings per share for the year ending Dec, 31 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ISEC Healthcare forms joint venture to build ophthalmology centre in Johor</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nISEC Healthcare forms joint venture to build ophthalmology centre in Johor\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time smaller\">2025-12-31 20:07</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to incorporate ISEC (Batu Pahat) Sdn. Bhd. in Malaysia.</p>\n<p>The new company will establish, operate and manage an ophthalmology centre in Batu Pahat, Johor. Initial issued capital will be 110 Malaysian ringgit shares, rising to RM1,064,890—about 0.34 million Singapore dollars—within nine months through new share subscriptions.</p>\n<p>After the capital increase, ISEC Sdn. Bhd. will own 71.83% of the joint venture, which will be treated as an indirect subsidiary of ISEC Healthcare.</p>\n<p>ISEC Healthcare will finance its contribution from internal resources. The firm said the transaction is classified as a non-discloseable event under Catalist Rule 1006 and will not materially affect its net tangible assets or earnings per share for the year ending Dec, 31 2025.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"40T.SI","symbol_name":"國際眼科中心","start_time":0,"source_url":"","article_id":"1119313168","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119313168","pubTimestamp":1767182879,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"40T.SI":"国际眼科中心"},"translate_title":"ISEC Healthcare成立合资企业在柔佛州建设眼科中心","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"40T.SI":1},"content_text":"ISEC Healthcare said on Dec, 31 2025 that its wholly-owned subsidiary, ISEC Sdn. Bhd., has signed a joint-venture agreement with Bond Infinity, K.C. Yeo Eye Specialist Clinic and Wedjat Vision to incorporate ISEC (Batu Pahat) Sdn. Bhd. in Malaysia.\nThe new company will establish, operate and manage an ophthalmology centre in Batu Pahat, Johor. Initial issued capital will be 110 Malaysian ringgit shares, rising to RM1,064,890—about 0.34 million Singapore dollars—within nine months through new share subscriptions.\nAfter the capital increase, ISEC Sdn. Bhd. will own 71.83% of the joint venture, which will be treated as an indirect subsidiary of ISEC Healthcare.\nISEC Healthcare will finance its contribution from internal resources. The firm said the transaction is classified as a non-discloseable event under Catalist Rule 1006 and will not materially affect its net tangible assets or earnings per share for the year ending Dec, 31 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}